304 related articles for article (PubMed ID: 26196942)
1. Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
Cho EJ; Kim MY; Lee JH; Lee IY; Lim YL; Choi DH; Kim YJ; Yoon JH; Baik SK
PLoS One; 2015; 10(7):e0133935. PubMed ID: 26196942
[TBL] [Abstract][Full Text] [Related]
2. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
Wang L; Feng Y; Ma X; Wang G; Wu H; Xie X; Zhang C; Zhu Q
PLoS One; 2017; 12(8):e0182969. PubMed ID: 28820885
[TBL] [Abstract][Full Text] [Related]
4. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
[TBL] [Abstract][Full Text] [Related]
5. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
Colecchia A; Montrone L; Scaioli E; Bacchi-Reggiani ML; Colli A; Casazza G; Schiumerini R; Turco L; Di Biase AR; Mazzella G; Marzi L; Arena U; Pinzani M; Festi D
Gastroenterology; 2012 Sep; 143(3):646-654. PubMed ID: 22643348
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
7. Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis.
Leeming DJ; Veidal SS; Karsdal MA; Nielsen MJ; Trebicka J; Busk T; Bendtsen F; Krag A; Møller S
Scand J Gastroenterol; 2015 May; 50(5):584-92. PubMed ID: 25639675
[TBL] [Abstract][Full Text] [Related]
8. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?
Hassan EM; Omran DA; El Beshlawey ML; Abdo M; El Askary A
Gastroenterol Hepatol; 2014 Feb; 37(2):58-65. PubMed ID: 24365388
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.
Kitson MT; Roberts SK; Colman JC; Paul E; Button P; Kemp W
Scand J Gastroenterol; 2015 Apr; 50(4):462-9. PubMed ID: 25623641
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
11. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.
Procopet B; Cristea VM; Robic MA; Grigorescu M; Agachi PS; Metivier S; Peron JM; Selves J; Stefanescu H; Berzigotti A; Vinel JP; Bureau C
Dig Liver Dis; 2015 May; 47(5):411-6. PubMed ID: 25732434
[TBL] [Abstract][Full Text] [Related]
12. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.
Fernandez M; Trépo E; Degré D; Gustot T; Verset L; Demetter P; Devière J; Adler M; Moreno C
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1074-9. PubMed ID: 26011235
[TBL] [Abstract][Full Text] [Related]
13. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive ménage à trois for the prediction of high-risk varices: stepwise algorithm using lok score, liver and spleen stiffness.
Stefanescu H; Radu C; Procopet B; Lupsor-Platon M; Habic A; Tantau M; Grigorescu M
Liver Int; 2015 Feb; 35(2):317-25. PubMed ID: 25228102
[TBL] [Abstract][Full Text] [Related]
15. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A
PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398
[TBL] [Abstract][Full Text] [Related]
16. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352
[TBL] [Abstract][Full Text] [Related]
17. The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis.
Ryu SR; Yoo JJ; Kang SH; Jeong SW; Kim MY; Cho YK; Chang Y; Kim SG; Jang JY; Kim YS; Baik SK; Kim YJ; Park SY; Baymbajav B
Clin Mol Hepatol; 2021 Jan; 27(1):197-206. PubMed ID: 33317252
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
Abraldes JG; Bureau C; Stefanescu H; Augustin S; Ney M; Blasco H; Procopet B; Bosch J; Genesca J; Berzigotti A;
Hepatology; 2016 Dec; 64(6):2173-2184. PubMed ID: 27639071
[TBL] [Abstract][Full Text] [Related]
19. Clinical Evaluation and Prognosis.
Hernández-Gea V; Berzigotti A
Dig Dis; 2015; 33(4):515-23. PubMed ID: 26159268
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
